Novavax (NVAX) Misses Q1 EPS by 13c; offers outlook
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $10.63 +0.28%
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
OCCI, IPX, ALZN, More
Financial Fact:
Research and development: 52.98M
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q1 EPS of ($1.05), $0.13 worse than the analyst estimate of ($0.92). Revenue for the quarter came in at $93.85 million versus the consensus estimate of $141.16 million.
GUIDANCE:
Novavax sees FY2024 revenue of $800 million to $1 billion, versus the consensus of $845.5 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
- Paychex (PAYX) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
